Skip to main content

Main navigation

  • Our Research
    • Find Diseases We Study
    • Rare Diseases Research Groups & Studies
    • Publications
  • For Patients
    • Patient Organizations
    • Survey on Impacts of COVID-19
    • Resources for Patients and Families
  • For Researchers
    • RDCRN Conference on Clinical Research for Rare Diseases (CCRRD)
      • Resources From Past CCRRD Conferences
    • RDCRN Training Opportunities
    • Other Rare Disease Initiatives
    • NIH Data Sharing
    • Resources for Researchers
  • News
  • COVID-19 Initiatives
  • About Us
facebook twitter linkedin RDCRN Members Login
Home
facebook twitter linkedin RDCRN Members Login
  • Our Research
    • Find Diseases We Study
    • Rare Diseases Research Groups & Studies
    • Publications
  • For Patients
    • Patient Organizations
    • Survey on Impacts of COVID-19
    • Resources for Patients and Families
  • For Researchers
    • RDCRN Conference on Clinical Research for Rare Diseases (CCRRD)
      • Resources From Past CCRRD Conferences
    • RDCRN Training Opportunities
    • Other Rare Disease Initiatives
    • NIH Data Sharing
    • Resources for Researchers
  • News
    • Latest News
    • Spotlight Newsletter
  • COVID-19 Initiatives
    • COVID-19 Resources for Researchers
    • COVID-19 Resources for Patients and Families
    • Survey on Impacts of COVID-19
  • About Us
    • About Us
    • Contact Us

Congenital disorders of glycosylation

Video abstract with graphic showing the process of O-glycosylation
Researchers Identify New Congenital Disorder of Glycosylation, GALNT2-CDG
May 26, 2020

Seven patients now have a name for their specific congenital disorder of glycosylation (CDG)—a new type called GALNT2-CDG. Researchers from Frontiers in Congenital Disorders of Glycosylation (FCDGC) describe the new disorder, caused by mutations in the GALNT2 gene, in the journal Brain.

Congenital disorders of glycosylation
CDG
FCDGC
Subscribe to Congenital disorders of glycosylation


Your participation makes a world of difference.
Learn How

Stay Up To Date With The Spotlight On Rare Diseases Newsletter

Subscribe

About Spotlight

Tweets by rarediseasesnet

Tags

primary ciliary dyskinesia
EGIDS
BBD
Genetic Disorders of Mucociliary Clearance Consortium
tremor
BVMC
Congenital and Perinatal Infections Rare Diseases Clinical Research Consortium
PCD
Scientist Spotlight
osteogenesis imperfecta

Footer Bottom Links

  • Contact Us
  • Website Policies
    • facebook
    • twitter
    • linkedin

The Rare Diseases Clinical Research Network (RDCRN) is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Office of Rare Diseases Research (ORDR). The RDCRN websites are hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke (NINDS) under grant number TR002818.